The substance known as "(gln11)-amyloid B-protein fragment 1-28," with the CAS number 106686-61-7, is a peptide fragment derived from the amyloid precursor protein (APP). This fragment consists of the first 28 amino acids of the amyloid beta (Aβ) peptide, which is implicated in the pathogenesis of Alzheimer's disease. The specific designation "(gln11)" indicates a modification at the 11th position of the amino acid sequence, which can influence the peptide's aggregation properties and biological activity. Characteristically, this peptide is hydrophilic and can form oligomers, which are associated with neurotoxicity and the formation of amyloid plaques in the brains of Alzheimer's patients. The fragment is often studied for its role in amyloidogenesis and its potential as a target for therapeutic interventions. Additionally, it can be utilized in research to understand the mechanisms of amyloid formation and the development of neurodegenerative diseases. Its stability, solubility, and interaction with other biomolecules are key areas of investigation in biochemistry and pharmacology.

(gln11)-amyloid B-protein fragment 1-28

106686-61-7: The substance known as "(gln11)-amyloid B-protein fragment 1-28," with the CAS number 106686-61-7, is a peptide fragment derived from the amyloid precursor protein (APP). This fragment consists of the first 28 amino acids of the amyloid beta (Aβ) peptide, which is implicated in the pathogenesis of Alzheimer's disease. The specific designation "(gln11)" indicates a modification at the 11th position of the amino acid sequence, which can influence the peptide's aggregation properties and biological activity. Characteristically, this peptide is hydrophilic and can form oligomers, which are associated with neurotoxicity and the formation of amyloid plaques in the brains of Alzheimer's patients. The fragment is often studied for its role in amyloidogenesis and its potential as a target for therapeutic interventions. Additionally, it can be utilized in research to understand the mechanisms of amyloid formation and the development of neurodegenerative diseases. Its stability, solubility, and interaction with other biomolecules are key areas of investigation in biochemistry and pharmacology.

Please enquire for more information about (Gln11)-Amyloid b-Protein (1-28) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

CAS 106686-61-7

(gln11)-amyloid B-protein fragment 1-28

(Gln11)-Amyloid b-Protein (1-28) trifluoroacetate salt

Ref: 3D-FG108659